Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Carcinoma, Anaplastic × Gefitinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 7 Lung Neoplasms 3 Respiratory Tract Diseases 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasms 1 Neoplasm Metastasis 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non-small Cell Lung Cancer 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 EGFR-mutant Non-small Cell Lung Cancer 1 Brain Neoplasms 1

Interventions

trametinib 5 dabrafenib 5 pembrolizumab 2 cobimetinib 2 atezolizumab 2 Vemurafenib 2 Radiotherapy, Intensity-Modulated 2 Paclitaxel 2 zimberelimab 1 tislelizumab 1 surufatinib 1 selpercatinib 1 lenvatinib 1 fludarabine 1 cemiplimab 1 cabozantinib 1 aldesleukin 1 abemaciclib 1 Taxes 1 Nivolumab 1 Ipilimumab 1 Immunoglobulin G 1 Disulfides 1 Cyclophosphamide 1 CTLA-4 Antigen 1 Bevacizumab 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡